AzurRx BioPharma Inc (AZRX.OQ)
AZRX.OQ on NASDAQ Stock Exchange Capital Market
2.45USD
12 Oct 2018
2.45USD
12 Oct 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$2.45
$2.45
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
17,412
17,412
52-wk High
$4.08
$4.08
52-wk Low
$2.19
$2.19
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.21 | December | 15 Oct 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 0 | 0 | 0 | 0 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 1 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 1 | -0.21 | -0.21 | -0.21 | -0.17 |
| Quarter Ending Mar-19 | 1 | -0.20 | -0.20 | -0.20 | -- |
| Year Ending Dec-18 | 1 | -0.91 | -0.91 | -0.91 | -0.67 |
| Year Ending Dec-19 | 1 | -0.72 | -0.72 | -0.72 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | -0.24 | -0.22 | 0.02 | -8.33 |
| Quarter Ending Mar-18 | -0.18 | -0.29 | 0.11 | -61.11 |
| Quarter Ending Dec-17 | -0.25 | -0.21 | 0.04 | -16.00 |
| Quarter Ending Sep-17 | -0.17 | -0.28 | 0.11 | -64.71 |
| Quarter Ending Jun-17 | -0.27 | -0.27 | 0.00 | -0.00 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | -0.21 | -0.21 | -0.21 | -0.21 | -0.17 |
| Quarter Ending Mar-19 | -0.20 | -0.20 | -0.21 | -0.21 | -- |
| Year Ending Dec-18 | -0.91 | -0.91 | -0.91 | -0.93 | -0.67 |
| Year Ending Dec-19 | -0.72 | -0.72 | -0.78 | -0.79 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Mar-19 | 0 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 1 | 0 |
Earnings vs. 
Estimates- BRIEF-Laurence W Lytton Reports 6.15 Pct Passive Stake In Azurrx Biopharma As Of May 1
- BRIEF-AzurRx Biopharma Announces Pricing Of $10.4 Mln Public Offering Of Common Stock
- BRIEF-Azurrx Biopharma Announces Proposed Public Offering Of Common Stock
- BRIEF-Azurrx Biopharma And Mayoly-Spindler Announce Additional Positive Interim Data For MS1819-SD Phase II
- BRIEF-Azurrx Biopharma Announces Positive Preclinical Data With AZX1103